Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Pharma Industry Analysis

UpdatedMay 25, 2025
DataAggregated Company Financials
Companies9
  • 7D0.8%
  • 3M-9.4%
  • 1Y8.8%
  • YTD2.6%

The Pharma industry is up 2.1% in the last week, with Novartis up 1.4%. This means that the industry has gained 7.7% over the past year. As for the next few years, earnings are expected to grow by 12% per annum.

Industry Valuation and Performance

Has the Swiss Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 25 May 2025CHF 436.0bCHF 118.8bCHF 19.2b25x22.7x3.7x
Tue, 22 Apr 2025CHF 413.0bCHF 117.3bCHF 18.4b24.6x22.4x3.5x
Thu, 20 Mar 2025CHF 482.1bCHF 121.3bCHF 19.1b29.4x25.2x4x
Sat, 15 Feb 2025CHF 475.3bCHF 122.3bCHF 19.1b22.9x24.9x3.9x
Mon, 13 Jan 2025CHF 444.2bCHF 120.1bCHF 21.5b18.5x20.7x3.7x
Wed, 11 Dec 2024CHF 423.4bCHF 117.9bCHF 21.1b18.1x20x3.6x
Fri, 08 Nov 2024CHF 441.0bCHF 117.2bCHF 21.0b19x21x3.8x
Sun, 06 Oct 2024CHF 445.7bCHF 115.4bCHF 19.4b21.1x23x3.9x
Tue, 03 Sep 2024CHF 479.4bCHF 115.0bCHF 19.3b22.9x24.8x4.2x
Thu, 01 Aug 2024CHF 467.4bCHF 116.5bCHF 19.7b22.6x23.8x4x
Sat, 29 Jun 2024CHF 434.0bCHF 116.4bCHF 19.8b33.7x21.9x3.7x
Mon, 27 May 2024CHF 409.2bCHF 117.4bCHF 19.9b42.1x20.5x3.5x
Wed, 24 Apr 2024CHF 400.2bCHF 113.5bCHF 20.0b37x20.1x3.5x
Fri, 22 Mar 2024CHF 386.7bCHF 111.7bCHF 19.4b37.9x20x3.5x
Sun, 18 Feb 2024CHF 380.8bCHF 110.4bCHF 19.7b23.9x19.3x3.4x
Tue, 16 Jan 2024CHF 415.7bCHF 119.6bCHF 18.7b27.1x22.2x3.5x
Thu, 14 Dec 2023CHF 405.6bCHF 120.9bCHF 18.9b25x21.5x3.4x
Sat, 11 Nov 2023CHF 385.0bCHF 122.7bCHF 19.1b23.4x20.2x3.1x
Mon, 09 Oct 2023CHF 405.3bCHF 122.0bCHF 18.7b26.3x21.7x3.3x
Wed, 06 Sep 2023CHF 398.0bCHF 112.2bCHF 18.0b47.4x22.1x3.5x
Fri, 04 Aug 2023CHF 410.7bCHF 114.8bCHF 19.3b48.1x21.3x3.6x
Sun, 02 Jul 2023CHF 421.0bCHF 115.1bCHF 18.9b36.9x22.3x3.7x
Tue, 30 May 2023CHF 433.0bCHF 115.6bCHF 18.9b39x22.9x3.7x
Thu, 27 Apr 2023CHF 425.7bCHF 114.9bCHF 18.8b41.2x22.6x3.7x
Sat, 25 Mar 2023CHF 394.1bCHF 115.9bCHF 19.0b40.2x20.8x3.4x
Mon, 20 Feb 2023CHF 406.9bCHF 116.2bCHF 19.0b28.5x21.4x3.5x
Wed, 18 Jan 2023CHF 438.2bCHF 117.0bCHF 34.6b23.2x12.7x3.7x
Fri, 16 Dec 2022CHF 443.4bCHF 117.3bCHF 34.7b23.2x12.8x3.8x
Sun, 13 Nov 2022CHF 450.3bCHF 118.2bCHF 35.1b23.4x12.8x3.8x
Tue, 11 Oct 2022CHF 441.7bCHF 121.6bCHF 37.5b20.7x11.8x3.6x
Thu, 08 Sep 2022CHF 451.4bCHF 120.7bCHF 37.1b21.2x12.2x3.7x
Sat, 06 Aug 2022CHF 452.8bCHF 119.7bCHF 36.6b21.1x12.4x3.8x
Mon, 04 Jul 2022CHF 448.3bCHF 118.7bCHF 37.4b27.2x12x3.8x
Wed, 01 Jun 2022CHF 467.0bCHF 118.5bCHF 37.3b29.1x12.5x3.9x
Price to Earnings Ratio

12.5x


Total Market Cap: CHF 467.0bTotal Earnings: CHF 37.3bTotal Revenue: CHF 118.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Pharma Industry Price to Earnings3Y Average 19.7x202320242025
Current Industry PE
  • Investors are optimistic on the Swiss Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 22.6x which is higher than its 3-year average PE of 19.7x.
  • The industry is trading close to its 3-year average PS ratio of 3.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 20% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market-0.92%
Healthcare-0.31%
Pharma0.84%
Pharma0.84%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NOVN NovartisCHF 92.761.4%
+CHF 2.5b		1.1%PE17.2x
SDZ Sandoz GroupCHF 40.473.5%
+CHF 594.4m		26.4%PS2x
GALD Galderma GroupCHF 102.201.3%
+CHF 308.6m		39.1%PE128x
ROG Roche HoldingCHF 259.900.08%
+CHF 159.1m		12.8%PE25x
COPN Cosmo PharmaceuticalsCHF 56.006.3%
+CHF 52.8m		-21.7%PE7.2x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

CURN

CHF 13.40

Curatis Holding

7D

25.2%

1Y

86.1%

SDZ

CHF 40.47

Sandoz Group

7D

3.5%

1Y

26.4%

ROG

CHF 259.90

Roche Holding

7D

0.08%

1Y

12.8%

GALD

CHF 102.20

Galderma Group

7D

1.3%

1Y

39.1%

Investors Appear Satisfied With Galderma Group AG's (VTX:GALD) Prospects As Shares Rocket 28%

May 20
Investors Appear Satisfied With Galderma Group AG's (VTX:GALD) Prospects As Shares Rocket 28%

NWRN

CHF 7.38

Newron Pharmaceuticals

7D

-6.1%

1Y

-22.5%

BIOV

CHF 34.60

BioVersys

7D

-0.3%

1Y

n/a

NOVN

CHF 92.76

Novartis

7D

1.4%

1Y

1.1%

Novartis' (VTX:NOVN) Performance Is Even Better Than Its Earnings Suggest

May 07
Novartis' (VTX:NOVN) Performance Is Even Better Than Its Earnings Suggest

ADXN

CHF 0.058

Addex Therapeutics

7D

4.7%

1Y

-16.2%

COPN

CHF 56.00

Cosmo Pharmaceuticals

7D

6.3%

1Y

-21.7%

DESN

CHF 207.00

Dottikon ES Holding

7D

-0.5%

1Y

-21.4%

Dottikon ES Holding AG's (VTX:DESN) Business Is Yet to Catch Up With Its Share Price

Feb 12
Dottikon ES Holding AG's (VTX:DESN) Business Is Yet to Catch Up With Its Share Price